Edition:
India

People: Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

5.45EUR
7 Aug 2020
Change (% chg)

€0.18 (+3.42%)
Prev Close
€5.27
Open
€5.29
Day's High
€5.64
Day's Low
€5.24
Volume
665,684
Avg. Vol
418,210
52-wk High
€5.74
52-wk Low
€1.78

Grimaud, Franck 

Mr. Franck Grimaud serves as President & Chief Business Officer and Member of the Executive Committee of the Company. He was Member of the Management Board, Co-President and Chief Business Officer of Valneva SE (Vivalis SA) as of the Company's merger in 2012. Previously he was the Chairman of the Management Board and the Executive Committee of Vivalis SA from November 29, 2002 to 2012. He holds a Master in Business Administration from Ottawa University, and started his career as an organization and management consultant. He then joined Groupe Grimaud as Head of Development for Asia and then became Head of Development of the Veterinary Vaccines Division before creating Vivalis. He was also appointed Vice Chairman of the Atlantic Biotherapies business cluster and his present and former positions include Chief Executive Officer of Smol Therapeutics SAS, President and Representative Director of Vivalis Toyama Japan KK, and Director of Grimaud Deyang Animal Co Ltd and Chengdu Grimaud Breeding Co Ltd.

Basic Compensation

Total Annual Compensation, EUR 397,575
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 19,795
Fiscal Year Total, EUR 417,370

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --